Although IRF4 has been clearly shown to impact ILC biology (65), antibody mediated ablation of ILC in fact leads to an aggravation of colitis (data not shown) and as previously published (50, 51) indicating that hampered ILC functionality is not likely to underlie the colitis protection observed in the absence of IRF4. The gene discussed is CCL27; the disease is colitis.